"10.1371_journal.pone.0101576","plos one","2014-07-07T00:00:00Z","Joshua W Wang; Subhashini Jagu; Chenguang Wang; Henry C Kitchener; Sai Daayana; Peter L Stern; Susana Pang; Patricia M Day; Warner K Huh; Richard B S Roden","Departments of Pathology, The Johns Hopkins University, Baltimore, Maryland, United States of America; Department of Biostatistics, The Johns Hopkins University, Baltimore, Maryland, United States of America; Department of Oncology, The Johns Hopkins University, Baltimore, Maryland, United States of America; Department of Gynecology and Obstetrics, The Johns Hopkins University, Baltimore, Maryland, United States of America; Womans Cancer Centre, St Marys Hospital, Institute of Cancer Sciences, University of Manchester, Manchester, United Kingdom; Paterson Building, Institute of Cancer Sciences, University of Manchester, Manchester, United Kingdom; Laboratory of Cellular Oncology, National Cancer Institute, Bethesda, Maryland, United States of America; Division of Gynecologic Oncology, University of Alabama at Birmingham, Birmingham, Alabama, United States of America","Conceived and designed the experiments: JWW WKH RBSR. Performed the experiments: JWW SJ SP PMD. Analyzed the data: JWW SJ CW SP PMD WKH RBSR. Contributed reagents/materials/analysis tools: HCK SD PLS WKH. Contributed to the writing of the manuscript: JWW CW HCK PLS WKH RBSR.","The authors have read the journals policy and have the following competing interests: Richard Roden and Subhashini Jagu are inventors of L2-related patents (US application 20090047301 Papillomavirus L2 N-Terminal Peptides for the Induction of Broadly Cross-Neutralizing Antibodies and US application 20130177585 PAPILLOMAVIRUS L2 N-TERMINAL PEPTIDES FOR THE INDUCTION OF BROADLY CROSS-NEUTRALIZING ANTIBODIES) licensed to Shantha Biotechnics Ltd., GlaxoSmithKline, PaxVax, Inc. and Acambis, Inc. Richard Roden has received research funding from Sanofi Pasteur, Shantha Biotechnic and GlaxoSmithKline and is a founder of Papivax LLC and scientific advisor to Papivax Biotech Inc. The terms of these arrangements are managed by Johns Hopkins University in accordance with its conflict of interest policies. This does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials.","2014","07","Joshua W Wang","JWW",10,TRUE,3,4,7,NA,TRUE,TRUE,FALSE,0,NA,FALSE
